Consultant Pharmacist Services | Clinical Expertise | Park Shore Pharmacon
Every long-term care facility in Florida that participates in Medicare or Medicaid has a federal obligation that most administrators encounter long before they encounter Park Shore Pharmacon: a licensed pharmacist must review every resident’s drug regimen on a regular basis, identify problems, and report findings to prescribers and the care team. This requirement traces back to the Omnibus Budget Reconciliation Act of 1987 (OBRA-87), which established the consultant pharmacist role in nursing facilities, and it remains codified today at 42 CFR 483.45(c), which requires that the drug regimen of each resident be free from unnecessary drugs.
That federal mandate is the legal foundation of consultant pharmacist services in long term care. But for the Florida LTC facilities Park Shore Pharmacon serves, the role of the consultant pharmacist has grown far beyond its OBRA origins into a comprehensive clinical oversight function that touches every aspect of medication management, from drug regimen review and prescriber communication to formulary oversight, survey preparation, and collaborative practice.
What Is a Consultant Pharmacist in Florida?
In most states, any licensed pharmacist can perform LTC consulting functions. Florida has a higher standard. Under Section 465.0125 of the Florida Statutes, “consultant pharmacist” is a separately licensed designation issued by the Florida Department of Health. To be licensed as a consultant pharmacist, a pharmacist must complete additional training as required by the Florida Board of Pharmacy. A consultant pharmacist may provide medication management services in a health care facility within the framework of a written collaborative practice agreement with a health care facility medical director or licensed physician.
This means that when Park Shore Pharmacon provides consultant pharmacist services to Florida LTC facilities, those services are delivered by pharmacists who hold a separate, active Florida consultant pharmacist license, not simply a standard pharmacy license. That distinction matters in two ways. First, it ensures the clinical and regulatory training that LTC consulting requires. Second, it protects your facility’s compliance standing during AHCA inspections and CMS surveys, which may verify that your consulting pharmacist holds the appropriate Florida licensure.
Park Shore Pharmacon’s consultant pharmacists are active members of the American Society of Consultant Pharmacists (ASCP), the professional organization that sets clinical and ethical standards for the consultant pharmacy practice nationally. Our pharmacists bring the clinical knowledge, regulatory familiarity, and institutional pharmacy experience that this specialized role demands.
Monthly Drug Regimen Review: The Core of Consultant Pharmacist Services
Federal regulations at 42 CFR 483.45(c) require that the drug regimen of each resident of a long term care facility be reviewed at least once a month by a licensed pharmacist, that the pharmacist report any irregularities to the attending physician and the director of nursing, and that the attending physician document any action taken in response to those irregularities.
The monthly Drug Regimen Review (DRR) is the clinical cornerstone of consultant pharmacist services in every LTC setting. At Park Shore Pharmacon, monthly DRR is not a perfunctory checklist. It is a comprehensive clinical review of every resident’s full medication profile, conducted by a licensed consultant pharmacist who understands both the clinical pharmacology of the drugs being reviewed and the regulatory standards against which those regimens will be evaluated.
Our monthly DRR process for every resident includes:
➤ Review for unnecessary drugs. Federal regulations define unnecessary drugs broadly: any medication used in excessive dose, for excessive duration, without adequate indication, without adequate monitoring, or in the presence of adverse consequences that indicate the dose should be reduced or the drug discontinued. Our consultant pharmacists apply this standard to every drug on every resident’s regimen, every month.
➤ Drug interaction and contraindication screening. Polypharmacy creates exponentially increasing interaction risk. Our pharmacists screen every resident’s full medication list for clinically significant drug-drug interactions, drug-disease contraindications, and drug-nutrient interactions that could affect therapeutic outcomes or resident safety.
➤ Potentially inappropriate medication review. Our pharmacists apply current evidence based criteria, including the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, to identify medications that may carry unacceptable risk in elderly populations and recommend appropriate therapeutic alternatives to prescribers.
➤ Psychotropic medication monitoring. Federal survey guidance places particular emphasis on antipsychotic and other psychotropic medications in LTC settings. Our consultant pharmacists review every psychotropic prescription for documented indication, appropriate dosing, evidence of gradual dose reduction attempts where applicable, and monitoring parameters consistent with federal quality indicators.
➤ Duplicate therapy identification. Therapeutic duplication, the same drug or two drugs from the same pharmacological class without clinical justification, is one of the most common and most correctable medication problems in LTC. Our DRR process identifies duplication systematically for every resident.
➤ Irregularity documentation and prescriber communication. When our consultant pharmacists identify a drug regimen irregularity, they prepare a documented report and communicate findings directly to the prescribing physician and the facility’s director of nursing. Physician responses to irregularity reports are documented in compliance with 42 CFR 483.45(c). These records are maintained at the facility for regulatory review.
Consultant Pharmacist Services Across Florida LTC Facility Types
Florida long term care settings require pharmacy consultation that reflects each facility’s regulatory framework and resident population. Park Shore Pharmacon provides consultant pharmacist services across licensed facility types throughout Florida. Our pharmacists support skilled nursing facilities with drug regimen reviews and psychotropic monitoring, while assisted living facilities receive medication oversight, record review, and staff education that align with applicable requirements.
Specialized residential programs require equally focused pharmacy workflows. Park Shore Pharmacon supports ICF/IID providers through our intermediate care facility pharmacy expertise, including regimen reviews and medication documentation. Our experience as a trusted LTC pharmacy for I/DD and care facilities also helps APD Waiver group homes manage complex medication profiles, psychotropic monitoring, and polypharmacy concerns under clinician direction.
Complex clinical populations benefit from targeted consultation. Park Shore Pharmacon integrates behavioral health facility pharmacy support for psychotropic medication review and interaction screening. Our hospice pharmacy services also support palliative and hospice programs with medication appropriateness reviews, comfort focused coordination, and controlled substance oversight.
Consultant Pharmacist Services Beyond Monthly DRR
The monthly DRR is a federal minimum requirement. For Florida LTC facilities seeking to optimize clinical outcomes, reduce survey risk, and support a genuine quality improvement culture around medication management, Park Shore Pharmacon’s consultant pharmacist services extend well beyond that baseline.
Medication Therapy Management
The University of Florida College of Pharmacy’s consultant pharmacist program describes the role as including collaboration with the healthcare team to provide recommendations for safe and effective drug therapy, guidance on regulatory compliance, facility medication utilization trends, and appropriate medication storage, in addition to performing medication regimen reviews based on each patient’s health history to evaluate the appropriateness, safety, benefits, risks, and cost effectiveness of medication therapy.
Our consultant pharmacists provide proactive medication therapy management (MTM) for complex residents whose medication regimens require more than a monthly review to manage safely. MTM engagements may include therapeutic recommendations following a new diagnosis or care transition, medication reconciliation after a hospital discharge, therapy optimization for residents with suboptimal clinical responses, and collaborative planning with prescribers for residents approaching or on hospice.
Collaborative Practice Agreements
Florida’s consultant pharmacist statute allows for written collaborative practice agreements between consultant pharmacists and facility medical directors or licensed physicians. Under a collaborative practice agreement, our consultant pharmacists may order and evaluate laboratory or clinical tests to monitor drug therapy, conduct patient assessments appropriate to evaluate medication therapy, and recommend modifications to drug regimens within the scope of the agreement.
For LTC facilities whose medical directors are interested in expanding the clinical role of pharmacy in their facilities, Park Shore Pharmacon’s consultant pharmacists are available to discuss collaborative practice agreement options that fit the facility’s clinical model and physician preferences.
Formulary Management and Pharmacy and Therapeutics Support
Our consultant pharmacists serve as a clinical resource for your facility’s formulary management, supporting the development and review of preferred drug lists, evaluating therapeutic equivalence for Medicaid and APD Waiver formulary compliance, and providing clinical input for the Pharmacy and Therapeutics committee functions that many LTC facilities maintain.
Survey Preparation and Regulatory Compliance
AHCA licensing surveys and CMS certification surveys both examine pharmacy services and medication management with significant rigor. For skilled nursing facilities, CMS survey guidance under the F-tag framework specifically addresses unnecessary drug use, psychotropic medication documentation, drug regimen review processes, and pharmacist reporting requirements. For ICF/IID facilities, 42 CFR 483.460 imposes quarterly drug regimen review requirements with specific documentation standards.
Park Shore Pharmacon’s consultant pharmacists support your facility’s survey preparation through pre-survey medication management audits, review of drug regimen review documentation for completeness and regulatory accuracy, staff education on medication related survey tags and how to address them, and direct consultation on any pharmacy related findings from prior surveys. Our consulting and training services describe the broader scope of our regulatory support for LTC facilities.
Connecting Consultant Pharmacist Services With Digital Medication Records
Effective consultant pharmacist services in 2025 are inseparable from a facility’s electronic records infrastructure. Park Shore Pharmacon integrates directly with the electronic medical record systems that Florida LTC facilities use most, including QuickMar and PointClickCare, to support real time medication order updates, documentation accuracy, and seamless access to the resident records our consultant pharmacists need to perform comprehensive drug regimen reviews.
Through the Park Shore Portal, your facility’s administrative and clinical team can access active medication order status, delivery documentation, and billing records in real time. Our technology integration platform is designed to reduce the documentation burden that manual pharmacy consultation processes create and give your staff and ours a shared, accurate view of every resident’s current medication picture.
This documentation infrastructure also supports the record keeping requirements for drug regimen review findings, irregularity reports, and physician responses that 42 CFR 483.45(c) and Florida pharmacy law require your facility to maintain and make available during regulatory inspection.
The Relationship Between Consultant Pharmacist Services and Your Pharmacy Delivery Program
At Park Shore Pharmacon, consultant pharmacist services and medication dispensing work together within one coordinated pharmacy program. Our teams share the information needed to support each facility’s medication management workflows, clinical communication, documentation responsibilities, and prescriber directed medication changes.
When our consultant pharmacist identifies a potential drug regimen irregularity during a scheduled review, Park Shore Pharmacon can coordinate communication with the appropriate prescriber while our dispensing team responds to any authorized prescription change. Formulary considerations, billing coordination, and medication profile updates remain connected within the same pharmacy relationship. New prescriptions following hospital discharge also enter a workflow that reflects the resident’s current medication profile and documented orders.
This integrated approach connects clinical review with practical LTC facility support, helping facilities maintain clearer medication profiles and more consistent pharmacy coordination. Park Shore Pharmacon also incorporates dependable delivery services into the same workflow, so prescriber authorized medications can move from pharmacist review and dispensing to scheduled or urgent delivery without separating clinical and operational pharmacy functions.
FAQs: Consultant Pharmacist Services in Florida LTC
- Does Florida require a separate consultant pharmacist license?
Yes. Florida requires consultant pharmacists to meet specific licensure requirements beyond standard pharmacist licensure. Park Shore Pharmacon works with qualified consultant pharmacists who support applicable facility compliance requirements.
- How often do skilled nursing facilities require drug regimen reviews?
Federal regulations generally require monthly drug regimen reviews for residents in participating nursing facilities. Park Shore Pharmacon provides consultant pharmacist services that support applicable review and documentation requirements.
- What does a drug regimen review examine?
Park Shore Pharmacon reviews medication profiles for potential interactions, unnecessary medications, contraindications, therapeutic duplication, dosage concerns, psychotropic medication considerations, and clinical monitoring needs under applicable standards.
- What happens when a consultant pharmacist identifies a drug regimen irregularity?
Park Shore Pharmacon documents identified irregularities and communicates relevant findings to appropriate facility staff and prescribers. Facilities and clinicians then follow applicable regulatory requirements for review, response, and documentation.
- Can consultant pharmacists work under collaborative practice agreements in Florida?
Florida law permits qualifying consultant pharmacists and physicians to establish written collaborative practice agreements within authorized scopes. Park Shore Pharmacon can discuss whether this arrangement fits your facility’s clinical model.
- How can facilities add Park Shore Pharmacon consultant pharmacist services?
Current partners can contact Park Shore Pharmacon directly, while new facilities can contact our team at (954) 874-4646 to discuss regulatory needs, clinical workflows, and consultant pharmacist services.
Contact Park Shore Pharmacon’s Clinical Team
Park Shore Pharmacon’s Florida licensed consultant pharmacists are available to serve LTC facilities across all 67 Florida counties as an integrated component of our full service pharmacy program. Whether your facility needs monthly DRR under 42 CFR 483.45(c), quarterly review under 42 CFR 483.460, collaborative practice engagement with your medical director, or comprehensive medication management support across a complex resident population, our consultant pharmacist services are designed to meet that need within the clinical and regulatory framework that Florida law requires. Contact us today to speak with a member of our clinical team.
Park Shore Pharmacon
600 Ansin Boulevard
Hallandale Beach, FL 33009
Phone: 954.874.4646
Fax: 954.455.1378
Toll-Free Fax: 1-855-464-7779
General Inquiries: customerservice@parkshoredrug.com
Billing Department Inquiries: billing@parkshoredrug.com
Serving Florida’s long term care facilities with licensed consultant pharmacist services since 1958. Proud Member: Florida Assisted Living Association
Disclaimer: Information on this page is provided for educational and informational purposes regarding pharmacy clinical and regulatory standards and does not constitute legal, regulatory, or compliance advice specific to your facility. Consult a licensed pharmacist, attorney, or compliance professional regarding your facility’s specific consultant pharmacist obligations under applicable federal and Florida law.